The primary treatment goals of ABPA include controlling symptoms of asthma or cystic fibrosis, preventing and/or treating pulmonary exacerbation, decreasing pulmonary inflammation, and reducing the ...
Please provide your email address to receive an email when new articles are posted on . Air pollution and genetic susceptibility increased the risks for progression from asthma to COPD, according to a ...
Spontaneous pneumomediastinum (SPM) refers to the presence of free air in the mediastinum without preceding trauma or iatrogenic cause.
Objective: To demonstrate that including the patient's perspective of disease control (patient-reported symptoms) in asthma treatment and management decisions improves patient outcomes and reduces ...
In this video, Rebecca Saff, MD, PhD, allergy/immunology fellowship director and assistant physician at Massachusetts General ...
asthma attack Which is a better predictor of morbidity in patients with severe asthma, blood eosinophil count or the number of patient-reported asthma triggers? The number of patient-reported triggers ...
Data from the KT-621 BROADEN2 Phase 2b AD patient trial expected to be reported by mid-2027KT-621 BREADTH Phase 2b trial in asthma on track to ...
Children’s Health Ireland (CHI) has apologised after a teenager with severe and poorly controlled asthma died following a ...
Dupilumab reduces mucus plugging and improves lung function in patients with moderate-to-severe type 2 asthma.
Biologic drugs for asthma may be initiated or continued while conceiving or during pregnancy or breastfeeding following appropriate risk-benefit discussions and shared decision-making, a consensus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback